• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Amneal`s Generic Esmolol Hydrochloride Receives Approval in the U.S.

    FDA

    HQ Spcs` Generic Esmolol Hydrochloride Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Esmolol Hydrochloride Receives Approval in the U.S.

    FDA

    Gland Pharma`s Generic Esmolol Hydrochloride Receives Approval in US

    FDA

    Mylan Adds CV Portfolio With Launch of Brevibloc Injection in Single-Dose Bags

    PR NEWSWIRE

    Sagent Pharms Generic Esmolol Hydrochloride Receives Approval In US

    FDA

    Mylan Labs Generic Esmolol Hydrochloride Receives Approval In US

    FDA

    Enforcement Report - Week of February 28, 2018

    FDA

    Gland Pharma`s Generic Esmolol Hydrochloride Approved In US

    FDA

    US FDA Enforcement Report- 18/May/2016

    FDA

    Hq Speciality`s Esmolol HCl approved in US for supraventricular tachyarrhythmias

    FDA

    Phase I/II trials for DFU potential drug successful: NovaLead

    ECONOMIC TIMES

    Luitpold`s Generic Esmolol Hydrochloride (Esmolol Hydrochloride 10Mg/mL) Approved in USA for Supraventricular Tachyarrhythmias And Noncompensatory Sinus Tachycardia.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.